Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies

v3.24.0.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

9. Commitments and contingencies

Purchase obligations

The Company had approximately $83,000 of outstanding purchase orders due within one year with its outside vendors and suppliers as of December 31, 2023. The Company has $2,057 accrued within accounts payable and other accrued expenses in the consolidated balance sheet as of December 31, 2023 related to estimated losses for firm commitment contractual obligations under these agreements. Losses on these firm commitment contractual obligations are recognized based upon the terms of the respective agreement and similar factors considered for the write-down of inventory, including expected sales requirements as determined by internal sales forecasts.

Warranty obligation

The following table identifies the changes in the Company’s aggregate product warranty liabilities for the years ended December 31, 2023, 2022 and 2021, respectively:

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Product warranty liability at beginning of period

 

$

19,913

 

 

$

13,726

 

 

$

14,394

 

Accruals for warranties issued

 

 

9,843

 

 

 

10,416

 

 

 

9,168

 

Adjustments related to preexisting warranties (including changes in estimates)

 

 

5,014

 

 

 

8,234

 

 

 

(597

)

Settlements made (in cash or in kind)

 

 

(11,292

)

 

 

(12,463

)

 

 

(9,239

)

Product warranty liability at end of period

 

$

23,478

 

 

$

19,913

 

 

$

13,726

 

 

During the year ended December 31, 2023, the Company recorded $5,014 of changes in estimates related to preexisting warranties due to data and information that became available during the current year. The changes in estimates were primarily due to the increased cost to repair for all products stemming from the current year inflationary environment and increased product failure rates.

Legislation and HIPAA

The healthcare industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government healthcare program participation requirements, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Compliance with government laws and regulations can be subject to future government review and interpretation as well as regulatory actions unknown or unasserted at this time. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) was enacted to ensure health insurance portability, reduce healthcare fraud and abuse, guarantee security and privacy of health information, and enforce standards for health information. The Health Information Technology for Economic and Clinical Health Act (HITECH Act), in part, imposes notification requirements of certain security breaches relating to protected health information. The Company is not aware of any pending claims against it under the HIPAA and HITECH regulations that are applicable to the Company’s business.

Legal proceedings

The Company is party to various legal proceedings and investigations arising in the normal course of business. The Company carries insurance, subject to specified deductibles under the policies, to protect against losses from certain types of legal claims. At this time, the Company does not anticipate that any of these other proceedings arising in the normal course of business will have a material adverse effect on the Company’s business. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.